Showing results (191-200 of 196) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 196 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2016
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH StudySarah Lilian Pett, Janaki Amin, Andrejz Horban, et al.
The International Journal on Drug Policy|June 24, 2025
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C studyJoshua Ang, Behzad Hajarizadeh, Shane Tillakeratne, et al.
The International Journal on Drug Policy|October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY studyEvan B Cunningham, Janaki Amin, Jordan J Feld, et al.
The Lancet. Gastroenterology & Hepatology|January 10, 2018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trialJason Grebely, Olav Dalgard, Brian Conway, et al.
The Lancet. HIV|July 4, 2021
Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation studyAndrew E Grulich, Fengyi Jin, Benjamin R Bavinton, et al.
The Lancet. HIV|October 22, 2018
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort studyAndrew E Grulich, Rebecca Guy, Janaki Amin, et al.
Pageof 20